Search

for
Search:

Sort by

Research

240-270 / 1000+ results

research Evaluating the safety profile of α-1 blockers, 5α-reductase inhibitors, and PDE5I for BPH: a disproportionality analysis of real-world adverse events based on FDA adverse event reporting system (FAERS)

March 2026 in “Figshare”

These medications for BPH have known risks and may have new side effects.

research Teriflunomide: a novel oral treatment for relapsing multiple sclerosis

16 citations , April 2014 in “Expert Opinion on Pharmacotherapy”

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

research Examination of Fluconazole-Induced Alopecia in an Animal Model and Human Cohort

6 citations , November 2018 in “Antimicrobial agents and chemotherapy (Print)”

Fluconazole can cause hair loss, but the exact cause is unknown.

research Clinical and metabolic effects of medroxyprogesterone acetate and ethinyl estradiol plus drospirenone in women with polycystic ovary syndrome

35 citations , July 2008 in “International Journal of Gynecology & Obstetrics”

MPA improved hormonal imbalances and acne in women with PCOS without affecting metabolism.

research Decision letter for "Repeated finasteride administration promotes synaptic plasticity and produces antidepressant‐ and anxiolytic‐like effects in female rats"

January 2024

research Decision letter for "Repeated finasteride administration promotes synaptic plasticity and produces antidepressant‐ and anxiolytic‐like effects in female rats"

September 2023

Non-Steroidal Modulation of the 5-Alpha Reductase Axis: A Dual Therapeutic Strategy for Prostatic Chemoprevention and Androgenetic Alopecia

research Non-Steroidal Modulation of the 5-Alpha Reductase Axis: A Dual Therapeutic Strategy for Prostatic Chemoprevention and Androgenetic Alopecia

January 2026 in “Zenodo (CERN European Organization for Nuclear Research)”

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

research 532P Analyses of patient-reported outcomes (PROs) with mirvetuximab soravtansine (MIRV) versus standard chemotherapy in the randomized phase III FORWARD I study in ovarian cancer (GOG 3011)

2 citations , September 2022 in “Annals of Oncology”

Mirvetuximab soravtansine improves quality of life and reduces symptoms more than standard chemotherapy in ovarian cancer patients.

In Vivo Evaluation of the Efficacy, Toxicity, and Biodistribution of PLGA-DMSA Nanoparticles Loaded with Itraconazole for Treatment of Paracoccidioidomycosis

research In vivo evaluation of the efficacy, toxicity and biodistribution of PLGA-DMSA nanoparticles loaded with itraconazole for treatment of paracoccidioidomycosis

8 citations , March 2018 in “Journal of Drug Delivery Science and Technology”

Itraconazole-loaded nanoparticles are more effective and less toxic for treating fungal infections than conventional oral itraconazole.

Validated HPTLC Method for the Simultaneous Determination of Alfuzosin, Terazosin, Prazosin, Doxazosin, and Finasteride in Pharmaceutical Formulations

research Validated HPTLC method for the simultaneous determination of alfuzosin, terazosin, prazosin, doxazosin and finasteride in pharmaceutical formulations

26 citations , July 2014 in “Analytical Chemistry Research”

Method can accurately measure five BPH drugs at once.

research Expression of Concern: Treatment of hirsutism by finasteride and flutamide in women with polycystic ovary syndrome

November 2024 in “Gynecological Endocrinology”

The article's findings are uncertain and should be viewed with caution.

research Bioequivalence Study of Two Different Coated Tablet Formulations of Finasteride in Healthy Volunteers

4 citations , December 2011 in “Drug Research”

Two finasteride tablet types are equally effective and can be swapped.

research Pharmacokinetics of Finasteride in the Elderly Volunteers.

1 citations , January 1995 in “Yakubutsu dōtai”

research Novel azaandrostane derivatives for the synthesis of 17β‐(N‐tert‐butyl carbamoyl)‐4‐aza‐5α‐androst‐1‐ene‐3‐one

3 citations , May 2007 in “Journal of Heterocyclic Chemistry”

A new method to make finasteride for hair loss treatment was developed.

research Inhibition of 5α-reductase attenuates behavioral effects of D1-, but not D2-like receptor agonists in C57BL/6 mice

42 citations , August 2012 in “Psychoneuroendocrinology”

Finasteride reduces certain behaviors caused by D1-like receptor agonists but not by D2-like receptor agonists in mice.

research Drug Therapy in Polycystic Ovarian Syndrome

November 2003 in “Aap Grand Rounds”

Low-dose flutamide-metformin therapy effectively improved PCOS symptoms in adolescent girls.

research New potential chemotherapy for ovarian cancer — Combined therapy with WP 631 and epothilone B

12 citations , March 2016 in “Life Sciences”

The new chemotherapy combination of WP 631 and Epothilone B shows enhanced effectiveness against ovarian cancer but requires more research on its safety.

research Fluoroquinolone-induced serious, persistent, multisymptom adverse effects

39 citations , October 2015 in “Case Reports”

Some people experience severe, long-lasting side effects from fluoroquinolone antibiotics, leading to the recommendation of limited use and increased awareness of these risks.